Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate

Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate (EDBu/OHPH/TCa), sold under the brand name Triormon Depositum, is an injectable combination medication of estradiol dibutyrate (EDBu), an estrogen, hydroxyprogesterone heptanoate (OHPH), a progestogen, and testosterone caproate (TCa), an androgen/anabolic steroid, which was used in the treatment of menopausal symptoms in women.^[1] It contained 3 mg EDBu, 30 mg OHPH, and 50 mg TCa in oil solution and was administered by intramuscular injection.^[1] The medication was developed by 1957.^[1] It is no longer available.^[2][3]

EDBu/OHPH/TCa

Combination of
Estradiol dibutyrate	Estrogen
Hydroxyprogesterone heptanoate	Progestogen
Testosterone cyclohexylpropionate	Androgen; Anabolic steroid
Clinical data
Trade names	Triormon Depositum
Other names	EDBu/OHPH/TCa
Routes of administration	Intramuscular injection

See also

• List of combined sex-hormonal preparations § Estrogens, progestogens, and androgens